|Security||WSCI / WSI Industries, Inc. (92932Q102)|
|President and CEO||PUDIL MICHAEL J|
|Industry||Metalworking Machinery And Equipment|
|Institutional Shares||342,623 - 11.54%|
|Common Shares Outstanding||2,970,283 shares (as of 2018-05-27)|
|Institutional Value||$ 1,468,000 USD|
Institutional Stock Ownership and Shareholders()
WSI Industries, Inc. (NASDAQ:WSCI) has 10 institutional investors and shareholders that have
filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 342,623 shares.
Largest shareholders include
BlackRock Institutional Trust Company, N.A., BlackRock Inc., Renaissance Technologies LLC, Bank Of America Corp /de/, Deutsche Bank Ag\, Panagora Asset Management Inc, BlackRock Fund Advisors, Acadian Asset Management Llc, Royal Bank Of Canada, and Morgan Stanley.
WSI Industries, Inc. (NASDAQ:WSCI) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.
Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/wsci"><img src="https://images.fintel.io/us-wsci-so.png" alt="WSCI / WSI Industries, Inc. Institutional Ownership"><a>
|DEUTSCHE BANK AG\||0||4,886||0||23|
|Renaissance Technologies LLC||88,900||106,100||19.35||533||520||-2.44|
|BANK OF AMERICA CORP /DE/||6,000||6,003||0.05||36||30||-16.67|
|PANAGORA ASSET MANAGEMENT INC||4,449||22|
|GRT CAPITAL PARTNERS L.L.C.||31,383||0||-100.00||188||0||-100.00|
|BlackRock Institutional Trust Company, N.A.||109,494||109,494||0.00||402||328||-18.41|
|BlackRock Fund Advisors||1,036||1,576||52.12||4||5||25.00|
|UBS Group AG||496||0||-100.00||3||0||-100.00|
|ROYAL BANK OF CANADA||1,223||607||-50.37||7||3||-57.14|
|WELLS FARGO & COMPANY/MN||1||0||-100.00||0||0|
|ACADIAN ASSET MANAGEMENT LLC||111||1,285||1,057.66||1||7||600.00|
7h - Asif
History and Development Himax Taiwan, its predecessor, was incorporated on June 12, 2001 as a limited liability company under the laws of the ROC. On April 26, 2005, the company established Himax Technologies Limited, an exempted company with limited liability under the Cayman Islands Companies Law, as a holding company to hold the shares of Himax Taiwan in connection with its reorganization and share exchange. On October 14, 2005, Himax Taiwan became its wholly owned subsidiary through a share exchange consummated pursuant to the ROC Business Mergers and Acquisitions Law through which the company acquired all of the issued and outstanding shares of Himax Taiwan, and the company issued ordinary shares to the shareholders of Himax Taiwan. Shareholders of Himax Taiwan received one of its ordinary shares in exchange for one Himax Taiwan common share. The share exchange was unanimously approved by shareholders of Himax Taiwan on June 10, 2005 with no dissenting shareholders and by ...
2018-06-22 - Asif
Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...
2018-06-22 - Asif
Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...
Related News Stories
Welcome everybody. We are about to begin the webinar first quarter 2018 financial review. Before we do so we will start with the Safe Harbor Statement and then I will turn the meeting over to Mr. Milton Todd Ault III, CEO and Chairman of the Board of DPW Holdings as well as Will Horne, CFO of DPW Holdings. (40-1)
Digital Power Corporation (NYSEMKT:DPW) Fourth Quarter and Full Year 2017 Financial Review Conference Call April 17, 2018 6:30 PM ET (40-3)
as of ET